Erythrodermic Psoriasis

• CLINICAL_TRIALS trial_result · 2026-07-30
  Clinical Trial Update: A Study of TAK-279 in Adult Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis [Phase 3]

  Phase 3 trial update for TAK-279 in adults with Generalized Pustular Psoriasis or Erythrodermic Psoriasis has completed.

• CLINICAL_TRIALS trial_result · 2026-01-28
  Clinical Trial Update: A Study of JNJ-77242113 for the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis [Phase 3]

  Phase 3 study of JNJ-77242113 for generalized pustular psoriasis and erythrodermic psoriasis is active but not recruiting, with results post…

• CLINICAL_TRIALS trial_result · 2026-01-28
  Clinical Trial Update: A Study of JNJ-77242113 for the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis [Phase 3]

  Phase 3 trial update for JNJ-77242113 in generalized pustular psoriasis and erythrodermic psoriasis; status active_not_recruiting with resul…

• CLINICAL_TRIALS trial_result · 2025-11-17
  Clinical Trial Update: A Study of TAK-279 in Adult Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis [Phase 3]

  TAK-279 is being studied in a Phase 3 trial for adults with generalized pustular psoriasis or erythrodermic psoriasis, and the study is curr…

• CLINICAL_TRIALS trial_result · 2025-06-19
  Clinical Trial Update: Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis)

  Pfizer's infliximab biosimilar was studied in a Drug Use Investigation for psoriasis indications; the trial has completed and results were p…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS other · 2025-01-30
  Clinical Trial Update: Efficacy of Injection Sekucinumab in Erythrodermic Psoriasis

  This clinical trial entry notes a study evaluating injections of Sekucinumab for erythrodermic psoriasis, with the study currently not recru…

• CLINICAL_TRIALS trial_result · 2021-08-13
  Clinical Trial Update: A Study of Ixekizumab (LY2439821) in Participants in Japan With Generalized Pustular Psoriasis and Erythrodermic Psoriasis [Phase 4]

  Phase 4 trial update for ixekizumab in Japanese participants with generalized pustular psoriasis and erythrodermic psoriasis; study complete…

• CLINICAL_TRIALS trial_result · 2019-12-11
  Clinical Trial Update: A Study to Test the Efficacy and Safety of Certolizumab Pegol in Japanese Subjects With Moderate to Severe Chronic Psoriasis [Phase 2, Phase 3]

  A Phase 2/Phase 3 trial evaluated the efficacy and safety of certolizumab pegol in Japanese patients with moderate to severe psoriasis, with…

• CLINICAL_TRIALS trial_result · 2019-10-24
  Clinical Trial Update: An Efficacy and Safety Study of CNTO1959 (Guselkumab) in the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis [Phase 3]

  Phase 3 clinical trial update for guselkumab (CNTO1959) in generalized pustular psoriasis and erythrodermic psoriasis has completed.

• CLINICAL_TRIALS trial_result · 2019-02-06
  Clinical Trial Update: A Study to Assess Efficacy and Safety of Two Different Dose Regimens of Risankizumab Administered Subcutaneously in Japanese Subjects With Generalized Pustular Psoriasis or Erythrodermic Psoriasis [Phase 3]

  Phase 3 trial evaluating two dose regimens of risankizumab subcutaneous in Japanese patients with generalized pustular psoriasis or erythrod…